| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |